Home › Uveal Melanoma › Colorado
Pag-aaral pangklinika para sa Uveal Melanoma sa Colorado
7 pag-aaral para sa Uveal Melanoma ang naghahanap ng mga kalahok sa mga site sa Colorado.
Mga Lungsod sa Colorado
Opisyal na teksto ng pag-aaral (English)
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
- University of Colorado Cancer Center, Aurora
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06070012A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
- SCRI Oncology Partners- Denver, Denver
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT06940739Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- SCRI - Denver, Denver
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 8, 2026 · NCT03947385ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Colorado, Anschutz Medical Campus, Aurora
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 13, 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- University of Colorado Hospital, Aurora
- The Melanoma and Skin Cancer Institute, Englewood
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora
- The Melanoma & Skin Cancer Institute, Englewood
Nagre-recruitPhase 2/3
Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
- Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 28, 2025 · NCT07136181Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.